Renowned Interventional Cardiologist Dr. Roxana Mehran Assumes Presidency of American College of Cardiology to Lead Global Health Initiatives

Dr. Roxana Mehran takes the helm of the American College of Cardiology, focusing on global partnerships and scientific innovation for 60,000 members.

By: AXL Media

Published: Mar 31, 2026, 3:36 AM EDT

Source: Information for this report was sourced from American College of Cardiology

A New Era of Global Cardiovascular Leadership

The American College of Cardiology has officially transitioned its executive leadership to Dr. Roxana Mehran, who began her one-year term as president today. Tasked with steering an organization that encompasses nearly 60,000 members worldwide, Mehran enters the role with a mandate to modernize cardiovascular care through enhanced global collaboration. During her inaugural address, she emphasized that the college serves as a primary defense against heart disease, with members operating on the front lines of diagnosis and treatment. According to Mehran, the institution's primary strength lies in its ability to transform high-level scientific evidence into practical, life-saving clinical applications.

Prioritizing Vulnerable Populations and Scientific Integrity

Central to Mehran’s presidency is a commitment to ensuring that medical advancements reach the most at-risk communities. She has voiced a vision rooted in the belief that cardiovascular health must be guided by rigorous science while remaining deeply empathetic to patient needs. By focusing on global partnerships, the new president intends to create a more unified approach to heart health that transcends national borders. Mehran noted that her optimism for the future of the college is driven by the collective expertise of its members and their shared dedication to ethical, evidence-based medicine.

Academic Excellence and Clinical Research Foundations

Dr. Mehran brings an extensive academic pedigree to the presidency, serving as an endowed professor of cardiovascular clinical research and outcomes at the Icahn School of Medicine at Mount Sinai. Her work in New York involves deep integration into both population health science and interventional cardiology, providing her with a unique perspective on how large-scale data impacts individual patient outcomes. As the director of the Women’s Heart and Vascular Center at Mount Sinai Fuster Heart Hospital, she has spent years developing multidisciplinary programs tailored to the specific physiological needs of female patients. This dual focus on research and specialized clinical care informs her approach to leading a diverse global medical body.